About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Universities of Giessen and Marburg Lung Center
›
top-articles
Universities of Giessen and Marburg Lung Center
234
(top 1%)
papers
8.4K
(top 1%)
citations
48
(top 1%)
h
-index
82
(top 1%)
g
-index
287
all documents
9.4K
doc citations
1.9K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Updated Treatment Algorithm of Pulmonary Arterial Hypertension
Journal of the American College of Cardiology
2013
596
2
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
Journal of the American College of Cardiology
2013
465
3
The transcriptional landscape and small RNAs of
Salmonella enterica
serovar Typhimurium
Proceedings of the National Academy of Sciences of the United States of America
2012
373
4
Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine
2012
296
5
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
Cell
2021
277
6
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis
Cell Stem Cell
2017
217
7
Macrophage and Cancer Cell Cross-talk via CCR2 and CX3CR1 Is a Fundamental Mechanism Driving Lung Cancer
American Journal of Respiratory and Critical Care Medicine
2015
186
8
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
European Respiratory Review
2017
183
9
Targeting renal fibrosis: Mechanisms and drug delivery systems
Advanced Drug Delivery Reviews
2018
167
10
Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
2018
127
11
Fgf10-Hippo Epithelial-Mesenchymal Crosstalk Maintains and Recruits Lung Basal Stem Cells
Developmental Cell
2017
123
12
Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity
Journal of Histochemistry and Cytochemistry
2018
118
13
TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes
Journal of Virology
2019
116
14
Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine
2017
113
15
Hypoxia-inducible factor signaling in pulmonary hypertension
Journal of Clinical Investigation
2020
104
16
Cystathionine γ Lyase Sulfhydrates the RNA Binding Protein Human Antigen R to Preserve Endothelial Cell Function and Delay Atherogenesis
Circulation
2019
103
17
Distinct Differences in Gene Expression Patterns in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis with Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine
2014
101
18
Evidence for the involvement of Fibroblast Growth Factor 10 in lipofibroblast formation during embryonic lung development
Development (Cambridge)
2015
100
19
Biomarkers in idiopathic pulmonary fibrosis
Matrix Biology
2018
99
20
FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury
Stem Cell Reports
2019
94
21
Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis
Respiratory Research
2015
89
22
Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension
European Respiratory Journal
2016
89
23
Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling
Proceedings of the National Academy of Sciences of the United States of America
2015
86
24
Between inflammation and thrombosis: endothelial cells in COVID-19
European Respiratory Journal
2021
86
25
When Place Matters: Shuttling of Enolase-1 Across Cellular Compartments
Frontiers in Cell and Developmental Biology
2019
83
26
Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury
Kidney International
2019
78
27
Classical Transient Receptor Potential Channel 1 in Hypoxia-induced Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine
2013
77
28
Cholinergic brush cells in the trachea mediate respiratory responses to quorum sensing molecules
Life Sciences
2012
75
29
Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension
JACC: Cardiovascular Imaging
2019
75
30
p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
American Journal of Respiratory Cell and Molecular Biology
2017
72
31
MicroRNA‐142
is a multifaceted regulator in organogenesis, homeostasis, and disease
Developmental Dynamics
2017
72
32
Legionella pneumophila-Derived Outer Membrane Vesicles Promote Bacterial Replication in Macrophages
PLoS Pathogens
2016
72
33
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin
Thorax
2015
71
34
IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
Nature Communications
2019
68
35
Severe organising pneumonia following COVID-19
Thorax
2021
68
36
A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia
Frontiers in Medicine
2015
67
37
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
FASEB Journal
2017
66
38
Targeting GLI Transcription Factors in Cancer
Molecules
2018
63
39
Biglycan is a new high-affinity ligand for CD14 in macrophages
Matrix Biology
2019
62
40
Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial
Journal of Heart and Lung Transplantation
2019
62
41
Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension
European Respiratory Journal
2019
62
42
Characterization of a Novel Fibroblast Growth Factor 10 (Fgf10) Knock-In Mouse Line to Target Mesenchymal Progenitors during Embryonic Development
PLoS ONE
2012
60
43
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study
Lancet Respiratory Medicine,the
2016
59
44
Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat
Cardiovascular Pathology
2015
57
45
Influenza Virus-Induced Caspase-Dependent Enlargement of Nuclear Pores Promotes Nuclear Export of Viral Ribonucleoprotein Complexes
Journal of Virology
2015
57
46
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Lancet Respiratory Medicine,the
2022
57
47
Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure
American Journal of Physiology - Lung Cellular and Molecular Physiology
2015
54
48
Microarray analysis in pulmonary hypertension
European Respiratory Journal
2016
54
49
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis
European Respiratory Journal
2018
54
50
Serotonin activates murine alveolar macrophages through 5-HT
2C
receptors
American Journal of Physiology - Lung Cellular and Molecular Physiology
2010
53
site/software ©
exaly
; All materials licenced under
CC by-SA
.